Skip to content

Clinical trials

Observational Hepatitis C, Chronic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C, Chronic Phase: Observational Clear all

214 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20032
20046
200517
200610
200712
20088
200911
201014
201114
201217
20134
20148
201518
201616
201713
201813
201915
20204
20213
20221
20233
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed151
Unknown status36
Terminated14
Withdrawn8
Recruiting3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC34
Hoffmann-La Roche27
AbbVie25
ANRS, Emerging Infectious Diseases5
Assiut University4
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)4
National Taiwan University Hospital4
Beijing Ditan Hospital3
Hospices Civils de Lyon3
Kirby Institute3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C, Chronic214
Hepatitis C73
Fibrosis11
Liver Cirrhosis11
Acquired Immunodeficiency Syndrome10
Hepatitis B, Chronic8
Liver Diseases6
Carcinoma, Hepatocellular5
HIV Infections5
Hepatitis5

Trials

Showing 1 to 25 of 214. Each trial links to its page on Pharma Observatory.

114 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.